ADVISORY/Nektar Sets Date and Conference Call for Fourth Quarter and Year Ended 2002 Financial Results.Business Editors/Medical & Health Writers SAN CARLOS San Carlos (săn kär`lōs), residential city (1990 pop. 26,167), San Mateo co., W Calif.; inc. 1925. The chief manufactures are plastic products, hardware, and machine parts. , Calif.--(BUSINESS WIRE)--Jan. 21, 2003 Nektar If you want to read about Czech Republic's beer Nektar. Nektar is a 1970s English progressive rock band based in Germany. History The band formed in Hamburg, Germany in 1969, members included Englishmen Roye Albrighton on guitars and vocals, Allan "Taff" Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. (Nasdaq:NKTR), formerly Inhale in·hale v. 1. To breathe in; inspire. 2. To draw something such as smoke or a medicinal mist into the lungs by breathing; inspire. Therapeutic Systems, Inc., will announce its financial results for the fourth quarter and year ended 2002 on Tuesday Tuesday: see week. , January 28, 2003. On that day, Robert Chess, Nektar Chairman, will host a conference call for analysts and investors beginning at 2:00 p.m., Pacific Time, to further discuss the company's financial results. Investors can access a live audio-only Webcast through a link that will be posted on the Investor Relations Investor relations The process by which the corporation communicates with its investors. site at Nektar's Web site at http://www.nektar.com. The Web broadcast of the conference call will be available for replay through February 11, 2003. Analysts and investors can also access the conference call live via telephone by dialing (888) 862-6557 (US); (630) 691-2748 (international). The passcode is Nektar and the leader is Mr. Rob Chess. An audio replay will be available shortly following the call through February 11, 2003 and can be accessed by dialing (630) 652-3018 with a passcode of 6700026. Inhale changed its name on January 15, 2003 to Nektar Therapeutics to reflect the company's broadened capabilities and approach to drug delivery. Nektar Therapeutics, formerly Inhale Therapeutic Systems, Inc., enables the development of differentiated, high-value pharmaceutical products based on its leading drug delivery technologies. Nektar's expanded technology and development expertise allows it to develop and offer to partners new product opportunities, solve more development challenges, and realize the full potential of their therapeutics from new molecular entities to life-cycle management products. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion